AdventHealth 2022 Liver Symposium Agenda

Saturday, September 24, 2022

7 to 8 am

Registration and Breakfast (opening remarks)

Doug Ross, MD, CMO
Iswanto Sucandy, MD
Adnan Muhammad, MD

Fatty Liver Session

8 to 8:20 am

Incidence, Pathophysiology, and Current Management of Fatty Liver Disease

Adnan Muhammad, MD
8:20 to 8:40 am

The Role of Medical Weight Management in the Treatment of NAFLD

Lisa Ferreira, MD
8:40 to 9 am

Current Role of Bariatric Surgery in the Treatment of Non-alcoholic Fatty Liver Disease

Michel Murr, MD
9 to 9:20 am

Panel Discussion with Q&A

All Speakers

Hepatitis C and Liver Cirrhosis Session

9:20 to 9:40 am

2022 Update on Diagnosis and Treatment of Hepatitis C

Angelo Fernandes, MD
9:40 to 10 am

Update on the diagnosis, management, and surveillance of patients with cirrhosis and portal hypertension.

Adnan Muhammad, MD
10 to 10:20 am

Role of Transplantation for Patients with Nonalcoholic and Alcoholic Liver Cirrhosis

John Leone, MD
10:20 to 10:40 am

Panel Discussion with Q&A

All Speakers
10:40 to 11 am

Morning Break

Bile Duct Obstruction/Bile Duct Cancer (Klatskin Tumor) Session

11 to 11:20 am

Utilization of Advanced Endoscopic Modalities for Diagnosis and Management of Patients with Klatskin Tumor

Michael Harris, MD
11:20 to 11:40 am

Modern Minimally Invasive Treatment and Clinical Outcomes After Klatskin Tumor Resection

Iswanto Sucandy, MD
11:40 to 12 pm

Panel Discussion with Q&A

All Speakers
12 to 1:10 pm


Colorectal Cancer with Liver Metastasis Session

1:10 to 1:30 pm

Oncological Treatment of Stage 4 Colorectal Cancer with Liver Metastasis. How to Administer Optimum Chemotherapy?

Faiza Manji, MD
1:30 to 1:50 pm

Resection of Colorectal Cancer with Liver Metastasis. How Do I Optimize the Oncological Outcomes In Collaboration with My Liver Surgeon?

Kim-Phung Nguyen, MD
1:50 to 2:10 pm

Update on Surgical Treatment of Metastatic Colorectal Cancer to the Liver. State of the Art Robotic Liver Resection

Iswanto Sucandy, MD
2:10 to 2:30 pm

Interventional Radiology Techniques for Patients with Unresectable Bilobar Liver Metastasis. Bland Embolization vs TACE vs Y-90?

Morgan Eckerd, MD
2:30 to 3 pm

Panel Discussion with Q&A and Wrap-up

All Speakers